UNITED STATES

SECURITIES AND EXCHANGE COMMISSION

WASHINGTON, D.C. 20549

FORM 8-K

CURRENT REPORT

Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934

Date of Report (Date of earliest event reported): February 15, 2019

China Health Management Corporation

(Exact name of registrant as specified in its charter)

Nevada	0-24273	75-2715335
(State or other jurisdiction of incorporation)	(Commission File Number)	(IRS Employer Identification No.)

3609 Hammerkop Dr. North Las Vegas, NV	89084
(Address of Principal Executive Offices)	(Zip Code)

Registrant's telephone number, including area code (415) 841-3570

Check the appropriate box below if the Form 8-K filing is intended to simultaneously satisfy the filing obligation of the registrant under any of the following provisions:

¨ Written communications pursuant to Rule 425 under the Securities Act (17 CFR 230.425)

¨ Soliciting material pursuant to Rule 14a-12 under the Exchange Act (17 CFR 240.14a-12)

¨ Pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act (17 CFR 240.14d-2(b))

¨ Pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act (17 CFR 240.13e-4(c))

Indicate by check mark whether the registrant is an emerging growth company as defined in Rule 405 of the Securities Act of 1933 (§230.405 of this chapter) or Rule 12b-2 of the Securities Exchange Act of 1934 (§240.12b-2 of this chapter).

Emerging growth company ☐

If an emerging growth company, indicate by check mark if the registrant has elected not to use the extended transition period for complying with any new or revised financial accounting standards provided pursuant to Section 13(a) of the Exchange Act.☐

Section 8 - Other Events

Item 8.01 Other Events.

The Company has been made aware of its recent stock trading activity due to speculation regarding a potential merger. The Company has no merger plans, no engagements with any merger candidates, and accordingly, management has not issued any press release, communication or Form 8-K disclosure document required pursuant to any merger. Any information to the contrary should not be relied upon.

SIGNATURES

Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned hereunto duly authorized.

China Health Management Corporation

(Registrant)

Date: February 19, 2019

By: /s/ Richard Chiang
Richard Chiang

President, Chief Executive Officer & Chairman

China Health Management Corp. 8-K